Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats. 2018

Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, 27710, USA. Electronic address: Azadi@duke.edu.

Smoking cessation strategies are of prime medical importance. Despite availability of various pharmacological agents in combating addiction to nicotine, more effective medications are needed. Based on recent findings, the glutamatergic system in the brain may provide novel targets. Here, we evaluated the effects of acute administration of sub-anesthetic doses of ketamine, an NMDA receptor antagonist, in both male and female Sprague-Dawley rats trained to self-administer nicotine. Animals were injected subcutaneously with 5, 7.5 and 10 mg/kg ketamine or saline and the effects on the number of intravenous nicotine infusions during a 45 min session was measured. Ketamine treatment significantly reduced nicotine self-administration in a dose-dependent manner. Moreover, a differential sensitivity between the sexes was observed as male rats responded to a lower dose of ketamine and with higher magnitude of effect than female rats. It is concluded that glutamatergic receptor manipulations may offer a novel and potentially sex-dependent intervention in nicotine addiction.

UI MeSH Term Description Entries
D007649 Ketamine A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors. 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone,CI-581,Calipsol,Calypsol,Kalipsol,Ketalar,Ketamine Hydrochloride,Ketanest,Ketaset,CI 581,CI581
D008297 Male Males
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors
D012646 Self Administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Administration, Self,Administrations, Self,Self Administrations
D014029 Tobacco Use Disorder Tobacco used to the detriment of a person's health or social functioning. Tobacco dependence is included. Nicotine Addiction,Nicotine Dependence,Nicotine Use Disorder,Tobacco Dependence,Tobacco-Use Disorder,Addiction, Nicotine,Dependence, Nicotine,Dependence, Tobacco,Disorder, Nicotine Use,Disorder, Tobacco Use,Disorder, Tobacco-Use,Nicotine Addictions,Nicotine Use Disorders,Tobacco Use Disorders
D016194 Receptors, N-Methyl-D-Aspartate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate

Related Publications

Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
August 2009, Progress in neuro-psychopharmacology & biological psychiatry,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
June 2008, Neuroscience,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
July 2020, Neurotoxicology,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
January 1979, NIDA research monograph,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
September 1984, British journal of pharmacology,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
December 1995, Psychopharmacology,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
November 2021, Drug and alcohol dependence,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
September 2008, Psychopharmacology,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
November 2003, Psychopharmacology,
Amir H Rezvani, and Yousef Tizabi, and Susan Slade, and Bruk Getachew, and Edward D Levin
January 2021, Frontiers in psychiatry,
Copied contents to your clipboard!